Merck's Breakthrough: Analysts React to Positive Drug Trial News
Analysts are optimistic about Merck's future after a 7.4% surge in shares following positive trial results.
Curaleaf's Hostile Bid for Aurora: Implications for Cannabis Investors
Curaleaf's hostile takeover bid for Aurora Cannabis raises critical questions for investors amid ongoing negotiations.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Amylyx Pharmaceuticals' 55% Surge: A Turning Point for Avexitide and Biotech Investors
Amylyx Pharmaceuticals saw a 55% surge following positive results from its avexitide trial, signaling strong investor co…
Moderna's Historic Phase 3 Cancer Vaccine Triumph: What Investors Need to Know
Moderna's stock saw a significant surge following its Phase 3 cancer vaccine success, indicating a pivotal moment for in…
Curaleaf's Hostile Takeover Bid: A Game Changer for the Cannabis Industry
Curaleaf's $4/share bid for Aurora Cannabis could reshape the cannabis landscape, creating ripples across the US and Can…
Hims & Hers Faces FTC Lawsuit: Implications for Telehealth Investors
Hims & Hers faces regulatory scrutiny, prompting a closer look at its telehealth business model and market sentiment.
BioMarin's Strategic Acquisition: What It Means for Investors
BioMarin's $275M acquisition of Alesta Therapeutics could enhance its rare disease focus and shareholder value.
30-Year Treasury Yield at 19-Year High: What It Means for US and Canadian Markets
The 30-year US Treasury yield has hit a 19-year high, reshaping market landscapes and investor strategies.
Curaleaf's Hostile Bid for Aurora Cannabis: Implications for North American Cannabis Investors
Curaleaf's $4/share bid for Aurora Cannabis signals major changes in the cannabis sector, impacting investors across the…
Amylyx Pharmaceuticals' Avexitide Phase 3 Success: What Investors Need to Know
Amylyx's Phase 3 success with avexitide shows promise for investors, especially amid past setbacks.
Nvidia's Strategic Move: Financing OpenAI's Data Center in Ohio
Nvidia's financing of OpenAI's data center marks a pivotal moment in AI infrastructure and investor sentiment.